PT  - JOURNAL ARTICLE
AU  - Musalula Sinkala
AU  - Panji Nkhoma
AU  - Mildred Zulu
AU  - Doris Kafita
AU  - Rabecca Tembo
AU  - Victor Daka
TI  - The COVID-19 Pandemic in Africa: Predictions using the SIR Model
AID  - 10.1101/2020.06.01.20118893
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.06.01.20118893
4099  - http://medrxiv.org/content/early/2020/07/31/2020.06.01.20118893.short
4100  - http://medrxiv.org/content/early/2020/07/31/2020.06.01.20118893.full
AB  - Since the earliest reports of the Coronavirus disease - 2019 (COVID-19) in Wuhan, China in December 2019, the disease has rapidly spread worldwide, attaining pandemic levels in early March 2020. However, the spread of COVID-19 has differed in the African setting compared to countries on other continents. To predict the spread of COVID-19 in Africa and within each country on the continent, we applied a Susceptible-Infectious-Recovered mathematical model. Here, our results show that, overall, Africa is currently (July 24, 2020) at the peak of the COVID-19 pandemic, after which we predict the number of cases would begin to fall in August 2020. Furthermore, we predict that the ending phase of the pandemic would be in Late-November 2020 and that decreasing cases of COVID-19 infections would be detected until around August 2021 and September 2021. Our results also reveal that of the 51 countries with reported COVID-19 cases, only eight, including Algeria, Morocco and Zambia, are likely to report higher monthly COVID-19 cases in the coming months of 2020 than those reported in the previous months. Overall, at the end of this pandemic, we predict that approximately 2,201,849 (about 1,451,567 future cases) individuals in Africa would have been infected with the COVID-19 virus. Here, our predictions are data-driven and based on the previously observed trends in the spread of the COVID-19 pandemic. Shifts in the population dynamics and/or changes in the infectiousness of the COVID-19 virus may require new forecasts of the disease spread.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNot ApplicableAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NoneAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available at covid.ourworldindata.org.